-
The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Sep 9, 2025, 16:22 PM -
Inpatient Burden of Influenza and Influenza-Like Illness Among Adults Aged 60 and Older in Germany 2019-2024
Sep 9, 2025, 16:22 PM -
Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes
Sep 9, 2025, 16:22 PM -
Economic Burden of Schizophrenia: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Understanding the Impact of Cost-Effectiveness Evaluations on Drug Pricing in Japan: A Case Study of Oncology Therapies
Sep 9, 2025, 16:22 PM -
Bimekizumab Improves Work Productivity in Patients With Hidradenitis Suppurativa: 2-Year Results From BE HEARD EXT
Sep 9, 2025, 16:22 PM -
Early Diagnosis and Treatment Optimization in Heart Failure Through NT-proBNP Testing in Primary and Specialist Care
Sep 9, 2025, 16:22 PM -
Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures
Sep 9, 2025, 16:22 PM -
Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Valuing Health States When Transitioning From Stage 2 to Stage 3 Type 1 Diabetes in a Sample of the General Population in the United Kingdom
Sep 9, 2025, 16:22 PM -
Semaglutide in Transition: A Nationwide Register-Based Study in Finland 2019-2024
Sep 9, 2025, 16:22 PM -
The VIS1ON Horizon Scanning Model: Predicting the Evolution of Direct NHS Expenditure for Type 1 Diabetes in Italy up to 2028
Sep 9, 2025, 16:22 PM -
Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future
Sep 9, 2025, 16:22 PM -
System-Level Economic Impact of a Combination Influenza-COVID-19 Vaccine vs. Standalone Vaccinations in the United Kingdom
Sep 9, 2025, 16:22 PM -
Exploring the Integration of Artificial Intelligence in Health Economic, Systematic Review, and Evidence Synthesis Methods: A Scoping Review of NICE Technology Appraisal and Assessment Reports
Sep 9, 2025, 16:22 PM -
Trends in Vaccination at Pharmacies by Race Among Medicaid Recipients: A Claims Analysis
Sep 9, 2025, 16:22 PM -
A Review of Cost Comparisons Submitted to NICE Since the Introduction of the Proportional Approach to Technology Appraisal
Sep 9, 2025, 16:22 PM -
Citizens’ Send Messages to Policy Makers Related to Primary Healthcare Practices: First Results From the Implementation of the Patient-Reported Indicator Surveys PaRIS in Greece
Sep 9, 2025, 16:22 PM -
The Use of Dynamic Models in Economic Evaluations in the UK and France
Sep 9, 2025, 16:22 PM -
Direct Economic Impact of Idiopathic Pulmonary Fibrosis on the Brazilian Private Healthcare System: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM
